Biography and Research Information
OverviewAI-generated summary
Mitchell Rotenberry's research focuses on the pharmacological effects and toxicity of certain compounds, particularly in the context of mitigating intestinal radiation toxicity. His recent publication in 2025, "Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity," highlights this area of investigation. Rotenberry collaborates with researchers at the University of Arkansas for Medical Sciences, including Rupak Pathak, Kathleen E. McGinness, Enoch K. Larrey, and H. Terence Cook, with whom he has shared publications. His work contributes to the broader field of health and medical research, exploring potential therapeutic strategies for radiation-induced damage.
Metrics
- Publications: 1
Selected Publications
-
Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity (2025)
Collaboration Network
Top Collaborators
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
Similar Researchers
Based on overlapping research topics